Coronavirus rapid test
Coronavirus rapid test iStock

Swiss multinational healthcare company Roche has announced that the Food and Drug Administration (FDA) has granted emergency use authorization for the company’s at-home COVID-19 test, The Hill reports.

The test, which uses a nasal swab sample, can produce "accurate, reliable and quick results in as few as 20 minutes," the company said in a statement released on Friday. The test will be available starting in January.

“The COVID-19 pandemic continues to shed light on the critically important role that rapid self-testing plays in empowering individuals to protect their personal health and the health of their families and communities,” Roche CEO Thomas Schinecker said in a statement.

The Biden administration this week announced plans to purchase 500 million COVID-19 rapid test kits and distribute them for free in January.

This were announced as part of President Joe Biden’s plan to fight the Omicron variant of COVID-19. The Centers for Disease Control and Prevention (CDC) said this week that Omicron is now the dominant version of the coronavirus in the US, accounting for 73% of new infections last week.

On Sunday, top US pandemic advisor Dr. Anthony Fauci warned of a “bleak winter” ahead as Omicron spurs a new wave of infections globally.

"One thing that's very clear... is (Omicron's) extraordinary capability of spreading," Fauci told NBC News. "It is just... raging through to the world."

Join our official WhatsApp group